[(4-carbobenzyloxy-1-piperazinyl)carbonyl]-L-phenylalanine | 114457-64-6

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: [(4-carbobenzyloxy-1-piperazinyl)carbonyl]-L-phenylalanine
• 英文别名: (2S)-3-phenyl-2-[(4-phenylmethoxycarbonylpiperazine-1-carbonyl)amino]propanoic acid
• CAS: 114457-64-6
• 化学式: C₂₂H₂₅N₃O₅
• 分子量: 411.458
• InChiKey: ITDUMLRKOPHXAC-IBGZPJMESA-N

物化性质

• 沸点：
  677.5±55.0 °C(predicted)
• 密度：
  1.303±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.3
• 重原子数：
  30
• 可旋转键数：
  7
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.32
• 拓扑面积：
  99.2
• 氢给体数：
  2
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  [(4-carbobenzyloxy-1-piperazinyl)carbonyl]-L-phenylalanine 在 palladium on activated charcoal 氢气 、 1-羟基苯并三唑 、 N,N'-二环己基碳二亚胺 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 25.0 ℃ 、101.33 kPa 条件下， 反应 17.5h， 生成 (2S,3R,4S)-2-<<(1-piperazinylcarbonyl)-L-phenylalanyl-L-histidyl>amino>-1-cyclohexyl-3,4-dihydroxy-6-methylheptane bis(acetic acid) salt
  参考文献：
  名称：

  Renin inhibitors. Dipeptide analogs of angiotensinogen utilizing a structurally modified phenylalanine residue to impart proteolytic stability

  摘要：

  A series of renin inhibitors have been prepared and evaluated for their susceptibility to cleavage by the serine protease chymotrypsin. The compounds were designed by consideration of the structural requirements in the active-site region of renin and chymotrypsin. By systematic alteration of the P3 phenylalanine residue, compounds with varying degrees of renin inhibitory potency and chymotrypsin susceptibility were obtained. Selected analogues from this group were examined in vivo for both their hypotensive effects and metabolic patterns.

  DOI：

  10.1021/jm00120a006
• 作为产物：
  描述：

  L-苯丙氨酸甲酯盐酸盐 在 lithium hydroxide 作用下， 以 1,4-二氧六环 、 二氯甲烷 、 水 、 甲苯 为溶剂， 反应 1.17h， 生成 [(4-carbobenzyloxy-1-piperazinyl)carbonyl]-L-phenylalanine
  参考文献：
  名称：

  Renin inhibitors. Dipeptide analogs of angiotensinogen utilizing a structurally modified phenylalanine residue to impart proteolytic stability

  摘要：

  A series of renin inhibitors have been prepared and evaluated for their susceptibility to cleavage by the serine protease chymotrypsin. The compounds were designed by consideration of the structural requirements in the active-site region of renin and chymotrypsin. By systematic alteration of the P3 phenylalanine residue, compounds with varying degrees of renin inhibitory potency and chymotrypsin susceptibility were obtained. Selected analogues from this group were examined in vivo for both their hypotensive effects and metabolic patterns.

  DOI：

  10.1021/jm00120a006

文献信息

• Novel Renin Inhibitors Containing (2S,3S,5S)-2-Amino-1-cyclohexyl-6-methyl-3,5-heptanediol Fragment as a Transition-state Mimic at the P1-P1' Cleavage Site.
  作者：Yasuki YAMADA、Koji ANDO、Yukishige IKEMOTO、Hiroki TADA、Eiji SHIRAKAWA、Eiji INAGAKI、Saizo SHIBATA、Ikuro NAKAMURA、Yoshiharu HAYASHI、Kiyoteru IKEGAMI、Itsuo UCHIDA

  DOI：10.1248/cpb.45.1631

  日期：——

  A series of renin inhibitors containing the (2S, 3S, 5S)-2-amino-1-cyclohexyl-6-methyl-3, 5-heptanediol (2-amino-3, 5-anti-diol) fragment as a novel transition-state mimic was synthesized, and their biological activities were evaluated. All of the synthesized compounds containing the 2-amino-3, 5-anti-diol fragment at the P1-P1' position showed high in vitro renin-inhibitory activity with IC50 values in the 10-8-10-10M range, and most of them caused a reduction of blood pressure when administered orally to salt-depleted, conscious marmosets. The inhibitor (29) with the 4-hydroxypiperidine residue at the P4 position showed the highest activity in terms of both potency and duration of the blood pressure-lowering effect.

  合成了一系列含有(2S, 3S, 5S)-2-氨基-1-环己基-6-甲基-3, 5-庚二醇（2-氨基-3, 5-反-二醇）片段作为新型过渡态模拟物的新型肾素抑制剂，并评价了它们的生物活性。所有在P1-P1'位置含有2-氨基-3, 5-反-二醇片段的合成化合物均表现出高体外肾素抑制活性，IC50值在10-8至10-10M范围内，并且大多数化合物在口服给盐缺乏的清醒狨猴时能降低血压。在P4位置含有4-羟基哌啶残基的抑制剂（29）在降低血压作用的强度和持续时间方面表现出最高的活性。
• LULY, JAY R.;PLATTNER, JACOB J.;DALE, J. KEMPF
  作者：LULY, JAY R.、PLATTNER, JACOB J.、DALE, J. KEMPF

  DOI：——

  日期：——
• Peptidylaminodiols
  申请人：ABBOTT LABORATORIES

  公开号：EP0229667B1

  公开（公告）日：1994-07-13
• PEPTIDYLAMINODIOLS
  申请人：ABBOTT LABORATORIES

  公开号：EP0295294A1

  公开（公告）日：1988-12-21
• EP0295294A4
  申请人：——

  公开号：EP0295294A4

  公开（公告）日：1990-04-10